Abilify and Fatigue - a phase IV clinical study of FDA data

Summary:

Fatigue is found among people who take Abilify, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Abilify and have Fatigue. It is created by eHealthMe based on reports of 90,519 people who have side effects when taking Abilify from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 22, 2023

90,519 people reported to have side effects when taking Abilify.
Among them, 3,524 people (3.89%) have Fatigue.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 98,584 Abilify users for its effectiveness, alternative drugs and more.

What is Fatigue?

Fatigue (feeling of tiredness) is found to be associated with 5,459 drugs and 6,221 conditions by eHealthMe.

Number of Abilify and Fatigue reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Fatigue?

Check whether Fatigue is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

Related studies

How severe was Fatigue and when was it recovered:

Fatigue in Abilify

Expand to all the drugs that have ingredients of aripiprazole:

Fatigue and drugs with ingredients of aripiprazole (4,707 reports)

Alternative drugs to, pros and cons of Abilify:

Abilify (98,584 reports)

Common Abilify side effects:

Weight increased: 6,809 reports
Stress and anxiety: 5,096 reports
Drug ineffective: 4,877 reports
Depression: 3,566 reports
Fatigue (feeling of tiredness): 3,524 reports
Suicidal ideation: 3,504 reports
Insomnia (sleeplessness): 3,232 reports

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Fatigue treatments and more:

Fatigue (905,049 reports)

COVID vaccines that are related to Fatigue:

Common drugs associated with Fatigue:

All the drugs that are associated with Fatigue:

Fatigue (5,459 drugs)

Common conditions associated with Fatigue:

Multiple sclerosis: 66,133 reports
Rheumatoid arthritis: 50,897 reports
Multiple myeloma: 30,410 reports
High blood pressure: 29,311 reports
Pain: 21,635 reports

All the conditions that are associated with Fatigue:

Fatigue (6,221 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.